Evidence map›Paper›PMID 41957069›Full record

ArticleScientific reports2026

Structural basis for TRF2-RAP1 recruitment by EBNA1 at the EBV origin of replication.

Samantha Sustek, Troy E Messick, Jayaraju Dheekollu, Coltin Albitz, Christopher Chen, Anneliese Faustino, Hsin-Yao Tang, Hee Jong Kim, Kenji Murakami, Paul M Lieberman

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Samantha SustekDepartment of Biochemistry and Biophysics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, 19104, USA.
Troy E MessickThe Wistar Institute, Philadelphia, PA, 19104, USA.
Jayaraju DheekolluThe Wistar Institute, Philadelphia, PA, 19104, USA.
Coltin AlbitzThe Wistar Institute, Philadelphia, PA, 19104, USA.
Christopher ChenThe Wistar Institute, Philadelphia, PA, 19104, USA.
Anneliese FaustinoThe Wistar Institute, Philadelphia, PA, 19104, USA.
Hsin-Yao TangThe Wistar Institute, Philadelphia, PA, 19104, USA.
Hee Jong KimDepartment of Biochemistry and Biophysics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, 19104, USA.
Kenji MurakamiDepartment of Biochemistry and Biophysics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, 19104, USA. kenjim@pennmedicine.upenn.edu.
Paul M LiebermanThe Wistar Institute, Philadelphia, PA, 19104, USA. lieberman@wistar.org.

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Role of TERRA in Telomere Maintenance and Telomere Stress ResponseR01CA140652 · NCI · WISTAR INSTITUTE · PI LIEBERMAN, PAUL M. · 2010 to 2025
$6.0M
Functional and structural studies of the transition from transcription initiation to elongationR01GM123233 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MURAKAMI, KENJI · 2017 to 2025
$3.6M
Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity SupplementR01CA259171 · NCI · WISTAR INSTITUTE · PI MESSICK, TROY E · 2021 to 2025
$3.3M
Advancing Cancer Research through Comprehensive Proteomics and Metabolomics AnalysesR50CA221838 · NCI · WISTAR INSTITUTE · PI Hsin-Yao Tang · 2017 to 2026
$2.1M
A New Cryo-Transmission Electron Microscope at Thomas Jefferson UniversityS10OD030457 · OD · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2022 to 2022
$2.0M
NCI NIH HHS 75N91019D00024NCI NIH HHS R01 CA140652NCI NIH HHS R01 CA259171NCI NIH HHS R50 CA221838NCI NIH HHS T32 CA009171NIH GM R01GM123233NIH HHS S10 OD030457
6 · The paper itself

Abstract

Epstein-Barr Nuclear Antigen 1 (EBNA1) is essential for the episomal maintenance and DNA replication of Epstein-Barr virus (EBV) in latently infected cells and acts through binding to oriP. The minimal replicative unit of oriP (½DS) contains four EBNA1 binding sites flanked by single telomeric nonamers that recruit shelterin proteins TRF2 and Rap1, but the structural basis for host-factor engagement is not known. Here, we integrate cryo-electron microscopy, zero-length cross-linking mass spectrometry, Alphafold3 modeling, and biochemical binding assays to define the complex formed by EBNA1-TRF2-Rap1 assembly on the ½DS. We find that a highly dynamic complex is formed, with the TRF2 homodimerization domain (TRFH) flexibly interacting with EBNA1 on the surface opposite the DNA-binding region, where there is a large acidic patch in EBNA1 that is unique amongst the herpesvirus episome maintenance proteins. Mutagenesis of this acidic patch abolishes TRFH binding and oriP-dependent plasmid replication. These findings identify a previously uncharacterized acidic patch docking surface on EBNA1 essential for coordinating TRF2-Rap1 at oriP and provide new insights into both EBV and telomere DNA replication.

Indexed as

Epstein-Barr Virus Nuclear AntigensHerpesvirus 4, HumanReplication OriginTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2Binding SitesCryoelectron MicroscopyDNA ReplicationHumansModels, MolecularProtein BindingShelterin ComplexVirus ReplicationEBV-encoded nuclear antigen 1Epstein-Barr Virus Nuclear AntigensShelterin ComplexTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2TERF2 protein, humanCryoEMEBNA1EBVhRAP1oriPShelterinTERF2TERF2IPTRF2

Identifiers

PMID41957069
PMCPMC13223232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.